Nitches Returns to Nutraceuticals, Opens Manufacturing Platform to Founders
Summary
Nitches, Inc. is strategically refocusing its operations on the nutraceutical market, offering its integrated manufacturing and intelligence platform to external founders. This new business model provides end-to-end support for supplement brands, covering formulation, compliance, manufacturing, and distribution. For a company of this size, this pivot into a service-based model within a growing market represents a material shift in its revenue strategy. Further details on the intelligence platform are expected in the coming weeks.
At the time of this announcement, NICH was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.00 to $66.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.